Vaxxas announces promising results in skin patch vaccine trial: A revolution in immunization

Vaxxas, a clinical-stage biotechnology company, has achieved a significant milestone in vaccine delivery technology. The company's innovative high-density microarray patch (HD-MAP) technology, which enables vaccines ... Read More